Myomo (MYO) E10: $-25.90 (As of Mar. 2026)


MYO Myomo Inc MYO
55 GF Score
Price $1.03
GF Value $3.12
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Myomo E10?

Myomo MYO -4.63% 55 E10 is $-25.90 as of Mar. 2026. GuruFocus rates MYO with a GF Score™ of 55/100 and a GF Value™ of $3.12 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Myomo's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-25.90 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-26), Myomo's current stock price is $1.03. Myomo's E10 for the quarter that ended in Mar. 2026 was $-25.90. Myomo's Shiller PE Ratio of today is .


Myomo  (AMEX:MYO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Myomo E10 Related Terms


Myomo E10 Historical Data

* Premium members only.

The historical data trend for Myomo's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Myomo E10 Chart

Myomo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Myomo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -25.90

MYO vs NSYS, NSPR, TELA: E10 Comparison

For the Medical Devices subindustry, Myomo's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Myomo Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Myomo's Shiller PE Ratio falls into.


MYO
55GF Score
Myomo Inc MYO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Myomo E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Myomo's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.07/330.2130*330.2130
=-0.070

Current CPI (Mar. 2026) = 330.2130.

Myomo Quarterly Data

per share eps CPI Adj_EPS
201606 -4.450 241.018 -6.097
201609 -5.667 241.428 -7.751
201612 -6.571 241.432 -8.987
201703 -8.169 243.801 -11.064
201706 -100.501 244.955 -135.481
201709 -6.300 246.819 -8.429
201712 -7.500 246.524 -10.046
201803 -6.000 249.554 -7.939
201806 -6.300 251.989 -8.256
201809 -6.300 252.439 -8.241
201812 -6.600 251.233 -8.675
201903 -6.820 254.202 -8.859
201906 -4.500 256.143 -5.801
201909 -4.870 256.759 -6.263
201912 -4.800 256.974 -6.168
202003 -2.510 258.115 -3.211
202006 -1.120 257.797 -1.435
202009 -0.700 260.280 -0.888
202012 -0.370 260.474 -0.469
202103 -0.570 264.877 -0.711
202106 -0.460 271.696 -0.559
202109 -0.360 274.310 -0.433
202112 -0.520 278.802 -0.616
202203 -0.410 287.504 -0.471
202206 -0.420 296.311 -0.468
202209 -0.400 296.808 -0.445
202212 -0.290 296.797 -0.323
202303 -0.110 301.836 -0.120
202306 -0.040 305.109 -0.043
202309 -0.060 307.789 -0.064
202312 -0.070 306.746 -0.075
202403 -0.100 312.332 -0.106
202406 -0.030 314.175 -0.032
202409 -0.030 315.301 -0.031
202412 -0.010 315.605 -0.010
202503 -0.080 319.799 -0.083
202506 -0.110 322.561 -0.113
202509 -0.090 324.800 -0.091
202512 -0.090 324.054 -0.092
202603 -0.070 330.213 -0.070

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-25.90 mean?
Myomo (MYO) has a E10 of $-25.90 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Myomo and its competitors.
Is Myomo's E10 too high?
Myomo's current E10 is $-25.90. Overall, Myomo has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Myomo's E10 compare to NSYS and NSPR?
Myomo's E10 of $-25.90 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Myomo and its competitors. Myomo's current E10 is $-25.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Myomo stock overvalued right now?
Based on GuruFocus' analysis, Myomo (MYO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.12, compared to a current price of $1.03 — trading 67% below its estimated fair value. The current E10 is $-25.90. Myomo's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Myomo (MYO), the current E10 is $-25.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Myomo (MYO) Overvalued in 2026?

Based on GuruFocus' analysis, Myomo stock appears to be undervalued. The current stock price of $1.03 is trading 67% below its estimated GF Value™ of $3.12. GuruFocus considers Myomo to be Possible Value Trap.

Key valuation signals for MYO:

  • E10: $-25.90
  • GF Value™: $3.12 vs. price of $1.03 (67% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the MYO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Myomo Business Description

Other Exchanges 0M61:Germany
Address 45 Blue Sky Drive, Suite 101, Burlington, MA, USA, 01803
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
55GF Score

Get the complete analysis for MYO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.03
Price
$3.12
GF Value